Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

被引:27
|
作者
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Zapletalova, Jana [1 ]
Stejskal, David [1 ]
Hlustik, Petr [1 ]
Kanovsky, Petr [1 ]
机构
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
关键词
Multiple sclerosis; CIS; RRMS; CSF; Inflammatory markers; Degenerative markers; TAU-PROTEIN; AXONAL DAMAGE; CYSTATIN-C; SUBGROUPS;
D O I
10.1179/016164110X12816242542535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Literature includes evidence of initial predominance of inflammation and later development of neurodegeneration in the pathogenesis of multiple sclerosis (MS). Objective: To search for differences in inflammatory and degenerative cerebrospinal fluid (CSF) markers between relapsing-remitting MS (RRMS) and the clinical isolated syndrome (CIS). Methods: A total of 148 subjects were evaluated, 65 MS patients (45 RRMS and 20 CIS) and 83 controls. The evaluated parameters included albumin quotient and prealbumin, transferrin, C3 and C4 complement factors, haptoglobin, beta-2-microglobulin, orosomucoid, alpha-1-antitrypsin, apolipoprotein A-I, apolipoprotein B, cystatin C, neuron-specific enolase, tau protein, beta-amyloid, oligoclonal IgG band (OCB), and IgG quotient (QIgG). Results: No differences were found in the inflammatory and degenerative CSF markers between patients with RRMS and CIS. QIgG was higher in RRMS than that in CIS but the number of OCB was higher after CIS. Cystatin C levels were significantly lower in RRMS compared to the other groups. It can be considered an indicator of the demyelination degree. Normal values of beta-amyloid were less frequent in RRMS compared to those in controls.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [31] Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
    Nocentini, U
    Pasqualetti, P
    Bonavita, S
    Buccafusca, M
    De Caro, MF
    Farina, D
    Girlanda, P
    Le Pira, F
    Lugaresi, A
    Quattrone, A
    Reggio, A
    Salemi, G
    Savettieri, G
    Tedeschi, G
    Trojano, M
    Valentino, P
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2006, 12 (01): : 77 - 87
  • [32] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Tomaž Omerzu
    Jožef Magdič
    Radovan Hojs
    Uroš Potočnik
    Mario Gorenjak
    Tanja Hojs Fabjan
    Wiener klinische Wochenschrift, 2024, 136 : 40 - 47
  • [33] Prevalence of of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Daniel, Sandi
    Tamas, Biernacki
    Szekeres, Dora
    Judit, Fuvesi
    Kincses, Zsigmond Tamas
    Csilla, Rozsa
    Matyas, Klotild
    Krisztian, Kasa
    Judit, Matolcsi
    Zboznovits, Dora
    Zita, Burany
    Eva, Langane
    Laszlo, Vecsei
    Krisztina, Bencsik
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 17 : 57 - 62
  • [34] Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation
    Berger, Benjamin
    Baumgartner, Annette
    Rauer, Sebastian
    Mader, Irina
    Luetzen, Niklas
    Farenkopf, Ulrich
    Stich, Oliver
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 282 : 118 - 122
  • [35] Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis
    Pavan, Karina
    Marangoni, Bruna E. M.
    Schmidt, Kizi B.
    Cobe, Femanda A.
    Matuti, Gabriela S.
    Nishino, Lucia K.
    Thomaz, Rodrigo B.
    Mendes, Maria Fernanda
    Lianza, Sergio
    Tilbery, Charles Peter
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2A) : 332 - 335
  • [36] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Omerzu, Tomaz
    Magdic, Jozef
    Hojs, Radovan
    Potocnik, Uros
    Gorenjak, Mario
    Fabjan, Tanja Hojs
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (1-2) : 40 - 47
  • [37] Screening for dysphagia in patients with relapsing-remitting multiple sclerosis
    Kocica, Jan
    Lasotova, Nadezda
    Kolcava, Jan
    Svobodova, Monika
    Hladikova, Magdalena
    Stourac, Pavel
    Bednarik, Josef
    Vlckova, Eva
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 83
  • [38] Neurovascular coupling in patients with relapsing-remitting multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 146 : 24 - 28
  • [39] Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis
    Achiron, A
    Barak, Y
    Rotstein, Z
    MULTIPLE SCLEROSIS, 2003, 9 (05): : 486 - 491
  • [40] Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Tizio, Santiago
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (08) : 574 - 577